<?xml version="1.0" encoding="UTF-8"?>
<p>Studies reported the repressive effects of aryl hydrocarbon receptor (AhR) agonists on ERα estrogen-sensitive cancer (endometrium and breast) cells (
 <xref rid="B171" ref-type="bibr">Tsuchiya et al., 2005</xref>; 
 <xref rid="B138" ref-type="bibr">Okino et al., 2009</xref>; 
 <xref rid="B109" ref-type="bibr">Marconett et al., 2010</xref>; 
 <xref rid="B92" ref-type="bibr">Labrecque et al., 2012</xref>). In line with this, the agonistic properties of AEL and compounds were evaluated. AEL exhibited a dose-dependent and significant AhR β-galactosidase activity from 5 μg/ml. The activity at 83 μg/ml was similar to that of 50 nM β-naphthoflavone (
 <xref rid="B11" ref-type="bibr">Ateba et al., 2013</xref>). For the first time, 
 <bold>44</bold> (EC
 <sub>50</sub> not determined) and 
 <bold>73</bold> (EC
 <sub>50</sub> of 1.34 µM) were found as partial agonists of AhR, whereas 
 <bold>43</bold> was not active (
 <xref rid="B12" ref-type="bibr">Ateba et al., 2014b</xref>).
</p>
